Candel Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Needham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Candel Therapeutics, Inc. has filed 402 SEC EDGAR filings since 16 Feb 2021

SEC filing history

Showing 101-125 of 402 matching filings.

Per page
25
Current page
5
4

4

Filing date
19 Mar 2025
Reporting date
17 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Mar 2025
Reporting date
17 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40629

144 filing

Filing date
18 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40629

144 filing

Filing date
18 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40629

144 filing

Filing date
18 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40629

144 filing

Filing date
17 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40629

144 filing

Filing date
17 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-285794

S-8

Filing date
13 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Feb 2025
Reporting date
21 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93359

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93359

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93359

SCHEDULE 13G/A filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93359

SCHEDULE 13G/A filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93359

SCHEDULE 13G filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Jan 2025
Reporting date
15 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Jan 2025
Reporting date
15 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .